Clinical Trial Update: Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the combination of thalidomide and hydroxyurea in patients with transfusion-dependent beta-thalassemia and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Thalidomide (thalidomide)

Snippet

Sponsor: Pakistan Blood and Marrow Transplant (PBMT) Group | Conditions: Transfusion Dependent Beta Thalassemia | Phase 2 | Status: RECRUITING